Clinical Trials
94
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (86 trials with phase data)• Click on a phase to view related trials
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
- First Posted Date
- 2024-05-06
- Last Posted Date
- 2025-11-06
- Lead Sponsor
- Amgen
- Target Recruit Count
- 88
- Registration Number
- NCT06401044
- Locations
- 🇺🇸
Applied Research Center of Arkansas, Little Rock, Arkansas, United States
🇺🇸Sarasota Retina Institute, Sarasota, Florida, United States
🇺🇸Vision Medical Research, Inc., Orland Park, Illinois, United States
A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Amgen
- Target Recruit Count
- 20
- Registration Number
- NCT06352892
- Locations
- 🇭🇰
Queen Mary Hospital, Hong Kong, Hong Kong
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2025-10-15
- Lead Sponsor
- Amgen
- Target Recruit Count
- 535
- Registration Number
- NCT06131398
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Alliance for Multispecialty Research - Kansas City, Merriam, Kansas, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2025-09-25
- Lead Sponsor
- Amgen
- Target Recruit Count
- 50
- Registration Number
- NCT06088199
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Affiliated Dermatology, Scottsdale, Arizona, United States
🇺🇸Clear Dermatology, Scottsdale, Arizona, United States
A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2025-11-03
- Lead Sponsor
- Amgen
- Target Recruit Count
- 100
- Registration Number
- NCT06079476
- Locations
- 🇮🇳
Stavya Spine Hospital and Research Institute SSHRI, Ahmedabad, Gujarat, India
🇮🇳MS Ramaiah Medical College and Hospitals, Bangalore, Karnataka, India
🇮🇳King Edward Memorial Hospital And Seth Gordhandas Sunderdas Medical College, Mumbai, Maharashtra, India
- Prev
- 1
- 2
- 3
- 4
- 5
- 19
- Next